BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,289,000 | -30.5% | 20,066 | -16.1% | 0.09% | -21.6% |
| Q1 2022 | $1,855,000 | -14.0% | 23,921 | -4.7% | 0.12% | -10.8% |
| Q4 2021 | $2,156,000 | +4.7% | 25,111 | -1.9% | 0.13% | -6.5% |
| Q3 2021 | $2,059,000 | -8.0% | 25,601 | -7.9% | 0.14% | -5.4% |
| Q2 2021 | $2,238,000 | -6.9% | 27,801 | -2.4% | 0.15% | -14.5% |
| Q1 2021 | $2,403,000 | -2.3% | 28,490 | -7.1% | 0.17% | -7.0% |
| Q4 2020 | $2,460,000 | -8.0% | 30,664 | -7.7% | 0.18% | -19.2% |
| Q3 2020 | $2,673,000 | -12.6% | 33,239 | -6.4% | 0.23% | -19.6% |
| Q2 2020 | $3,057,000 | +6.8% | 35,511 | +0.7% | 0.28% | -17.6% |
| Q1 2020 | $2,863,000 | +19.4% | 35,265 | +31.7% | 0.35% | +39.5% |
| Q4 2019 | $2,398,000 | +2.2% | 26,773 | -0.2% | 0.25% | -12.7% |
| Q3 2019 | $2,346,000 | +13.5% | 26,816 | +6.2% | 0.28% | +12.7% |
| Q2 2019 | $2,067,000 | +2.8% | 25,243 | +2.1% | 0.25% | -2.3% |
| Q1 2019 | $2,010,000 | +35.5% | 24,720 | +9.7% | 0.26% | +8.9% |
| Q4 2018 | $1,483,000 | -8.7% | 22,526 | +6.9% | 0.24% | +8.2% |
| Q3 2018 | $1,625,000 | +10.8% | 21,075 | +6.1% | 0.22% | -11.7% |
| Q2 2018 | $1,466,000 | +18.8% | 19,858 | +4.7% | 0.25% | +8.8% |
| Q1 2018 | $1,234,000 | +5.7% | 18,967 | +13.8% | 0.23% | +9.6% |
| Q4 2017 | $1,167,000 | +42.8% | 16,668 | +27.9% | 0.21% | +30.0% |
| Q3 2017 | $817,000 | -0.6% | 13,027 | -4.0% | 0.16% | -17.1% |
| Q2 2017 | $822,000 | +41.7% | 13,574 | +21.5% | 0.19% | +24.5% |
| Q1 2017 | $580,000 | +3.4% | 11,176 | -11.7% | 0.16% | -8.3% |
| Q4 2016 | $561,000 | -10.0% | 12,659 | -3.3% | 0.17% | -18.8% |
| Q3 2016 | $623,000 | +7.2% | 13,097 | +1.9% | 0.21% | +2.5% |
| Q2 2016 | $581,000 | +18.3% | 12,850 | +7.6% | 0.20% | +10.9% |
| Q1 2016 | $491,000 | +102.9% | 11,946 | +88.1% | 0.18% | +120.5% |
| Q4 2015 | $242,000 | +16.9% | 6,351 | +0.9% | 0.08% | -4.6% |
| Q3 2015 | $207,000 | -66.6% | 6,293 | -30.1% | 0.09% | -63.4% |
| Q2 2015 | $620,000 | +30.5% | 9,008 | +30.0% | 0.24% | +17.8% |
| Q1 2015 | $475,000 | -12.7% | 6,929 | -6.7% | 0.20% | -15.8% |
| Q4 2014 | $544,000 | +10.6% | 7,427 | +8.3% | 0.24% | -14.6% |
| Q3 2014 | $492,000 | +38.6% | 6,859 | +39.7% | 0.28% | +60.6% |
| Q2 2014 | $355,000 | -1.4% | 4,909 | +0.3% | 0.18% | -11.6% |
| Q1 2014 | $360,000 | +11.8% | 4,895 | +5.8% | 0.20% | +7.0% |
| Q4 2013 | $322,000 | +3.9% | 4,626 | -2.1% | 0.18% | -16.7% |
| Q3 2013 | $310,000 | -8.0% | 4,723 | -2.8% | 0.22% | -19.6% |
| Q2 2013 | $337,000 | – | 4,859 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |